FDA Drafts 21 New Product-Specific Guidances for Generics, Revises 16

Generic Line
A A
The FDA published 21 new and 16 revised product-specific draft guidances, outlining methods for establishing bioequivalence for generics.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00